Dow Down 0.62% Nasdaq Down 1.14%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
5.28 Down 0.17(3.12%) Sep 22, 4:00PM EDT
|After Hours : 5.21 Down 0.07 (1.33%) Sep 22, 6:31PM EDT
Prev Close:5.45
Open:5.45
Bid:5.21 x 100
Ask:5.31 x 3000
1y Target Est:5.00
Beta:2.85
Next Earnings Date:N/A
Day's Range:5.25 - 5.51
52wk Range:3.10 - 10.64
Volume:438,561
Avg Vol (3m):648,558
Market Cap:314.18M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NWBO

Comparison

Symbol% ChgMkt Cap
NWBODown 3.12%314.18M
AGENDown 1.37%180.52M
DNDNUp 2.67%239.36M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):810.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback